Armata Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,169 | $491 | $1,235 | $2,973 |
Gross Profit | 1,803 | 114 | 855 | 2,660 |
EBITDA | -12,121 | -2,552 | 6,260 | -2,245 |
EBIT | -12,487 | -2,929 | 5,880 | -2,558 |
Net Income | -16,295 | -6,531 | 2,600 | -5,481 |
Net Change In Cash | 2,169 | 491 | 1,235 | 2,973 |
Free Cash Flow | -7,360 | -7,679 | -7,850 | -9,203 |
Cash | 4,328 | 11,688 | 9,291 | 17,141 |
Basic Shares | 36,193 | 36,185 | 59,082 | 36,180 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,174 | $4,529 | $5,508 | $4,474 |
Gross Profit | 3,849 | -29,241 | 4,616 | -15,541 |
EBITDA | -6,849 | -39,918 | -36,054 | -22,648 |
EBIT | -8,174 | -40,890 | -36,946 | -23,817 |
Net Income | -18,916 | -69,045 | -36,917 | -23,155 |
Net Change In Cash | 5,174 | 4,529 | 5,508 | 4,474 |
Cost of Revenue | 9,324 | 639 | ||
Free Cash Flow | -39,430 | -55,567 | -34,692 | -24,879 |
Cash | 9,291 | 13,523 | 14,852 | 10,288 |
Basic Shares | 59,060 | 36,076 | 34,294 | 24,104 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.45 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.23 |
